Elisabeth Crönert-Bendell joined Rhythm in April 2021 bringing over 20 years of country level, regional and global strategy and commercial experience in specialty care and rare diseases. Most recently, she was Head of the Neuroscience Business Franchise and Head of New Product Planning at Kyowa Kirin International. Prior to that, she was a senior vice president at Sanofi where she led the strategy for Neuroscience and Rare Disease at the Genzyme Business Unit. Elisabeth also worked in strategic consulting at Monitor (now Monitor-Deloitte). She also held leadership roles of increasing responsibility in Sanofi from Sales & Marketing roles in the French affiliate to global positions (head of the rare cardio franchise, head of new product planning). Elisabeth is a physician who specializes as a neurologist and holds an MBA from INSEAD.